Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SKYE | AZN | AMGN | GILD | BMY |
| Company | Skye Bioscience Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.0300 | 95.30 | 328.97 | 124.31 | 56.73 |
| High | 1.0300 | 95.36 | 332.50 | 124.57 | 57.00 |
| Low | 0.9402 | 93.41 | 325.19 | 120.94 | 55.34 |
| Latest | 0.9626 | 93.99 | 330.03 | 121.26 | 56.62 |
| Change | -0.0574 | -2.35 | +1.06 | -2.81 | -0.40 |
| % Change | -5.63% | -2.44% | +0.32% | -2.26% | -0.70% |
| Volume | 363,200 | 9,146,600 | 2,592,000 | 6,659,700 | 11,845,600 |
| 20-Day Average Volume | 633,770 | 5,408,955 | 2,673,355 | 6,271,805 | 14,383,125 |
| Previous Close | 1.0200 | 96.34 | 328.97 | 124.07 | 57.02 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9218 | 92.89 | 328.92 | 122.74 | 54.82 |
| 20-Day Raw Stochastic | 53.96% | 63.90% | 47.58% | 41.60% | 91.57% |
| 20-Day Relative Strength | 43.31 | 56.73 | 52.50 | 48.39 | 65.87 |
| Weighted Alpha | -53.47 | +43.56 | +21.88 | +26.92 | +10.28 |
| Today's Opinion | 88% Sell | 100% Buy | 80% Buy | 40% Buy | 100% Buy |
| Previous Opinion | 88% Sell | 100% Buy | 64% Buy | 72% Buy | 88% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 72% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.32% since 01/08/26 | -0.02% since 01/08/26 | -0.02% since 01/08/26 | +0.49% since 01/08/26 | +1.29% since 01/08/26 |
| Low | 0.9350 on 01/13/26 | 92.78 on 01/13/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 55.33 on 01/15/26 |
| High | 1.1000 on 01/14/26 | 96.43 on 01/14/26 | 332.50 on 01/15/26 | 124.57 on 01/15/26 | 57.04 on 01/14/26 |
| 1-Month | |||||
| %Chg | -10.87% since 12/15/25 | +2.65% since 12/15/25 | +1.45% since 12/15/25 | +1.24% since 12/15/25 | +4.29% since 12/15/25 |
| Low | 0.6844 on 12/31/25 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 1.2000 on 12/17/25 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 57.04 on 01/14/26 |
| 3-Month | |||||
| %Chg | -37.08% since 10/15/25 | +10.80% since 10/15/25 | +11.00% since 10/15/25 | +2.50% since 10/15/25 | +29.83% since 10/15/25 |
| Low | 0.6844 on 12/31/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 1.6600 on 10/27/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| 6-Month | |||||
| %Chg | -74.26% since 07/15/25 | +33.66% since 07/15/25 | +12.83% since 07/15/25 | +11.19% since 07/15/25 | +21.95% since 07/15/25 |
| Low | 0.6844 on 12/31/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 42.52 on 10/29/25 |
| High | 4.9902 on 10/03/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 32,698 | 298,793,856 | 177,144,096 | 153,931,168 | 116,078,640 |
| Shares Outstanding, K | 32,057 | 3,101,452 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -26,570,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -12,750,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 2.68 | 0.34 | 0.45 | 0.33 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 11/10/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 |
| Latest Earnings Date | 03/19/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.68 | 14.83 | 14.87 | 8.52 |